C57BL/6 (CD45.2), B6.CH-2bm1 (bm1), OT-I.CD45.1, OT-II.CD45.1, CCR2 KO, and BALB/c mice were bred in-house and housed in specific pathogen–free conditions in the animal facility at the Doherty Institute of Infection and Immunity, the University of Melbourne. All experiments were done in accordance with the Institutional Animal Care and Use Committee guidelines of the University of Melbourne. Mice were infected intranasally in the URT with 104 plaque-forming units (PFU) of x31-OVA1 (encodes the OVA257–264 epitope within the neuraminidase stalk) (7) or 104 PFU of x31-OVA2 (encodes the OVA323–339 epitope within the neuraminidase stalk) (8) in a volume of 10 μl. In some experiments, mice received an URT infection with 105 PFU of PR8-LAIV, which was generated as described (37). Mice were infected intranasally with 108 CFU of S. aureus [JKD6159, CA-MRSA (ST93) (38)] or S. aureus (Newman, MSSA CC8) (39) (40) in a volume of 10 μl as previously described (41).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.